Meridia (sibutramine) / AbbVie 
Welcome,         Profile    Billing    Logout  

7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Meridia (sibutramine) / AbbVie
2005-002080-88`ACTRN12616001707459: A double−blind, placebo−controlled crossover trial to quantify the effects of sibutramine on energy intake and energy expenditure in obese subjects during a test meal

Ongoing
4
36
Europe
Reductil 10 mg, Reductil 15 mg, PL 00037/0326, PL 00037/0327, Reductil 10 mg, Reductil 15 mg, Reductil 10 mg, Reductil 15 mg
Aintree Hospitals NHS Trust and University of Liverpool, The Prostate Cancer Foundation of Australia: Movember Clinical Trial Award
Prostate Cancer progression, Vitamin D in preventing prostate cancer progression
 
 
2009-013737-24: TRATAMIENTO MULTIDISCIPLINARIO DE LA OBESIDAD MÓRBIDA: MEDICAMENTOS, TERAPIA DE COMPORTAMIENTO, APOYO NUTRICIONAL Y ACTIVIDAD FÍSICA. ESTDIO TRAMOMTANA

Ongoing
4
60
Europe
Reductil, 63823,
HOSPITAL UNIVERSITARIO SON DURETA. UNIDAD DE INVESTIGACIÓN
terapia complementaria dentro de un programa integral parael control del peso en:- Pacientes con obesidad, cuyo IMC (Índice de Masa Corporal) es 30 kg/m2 o superior- Pacientes con sobrepeso, cuyo IMC es 27 kg/m2 o superior, que presenten otros factoresde riesgo asociados a la obesidad como diabetes tipo 2 o dislipidemia.
 
 
NCT05821543: Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity

Completed
4
240
RoW
metformin+sibutramine, Reduxin® Forte, sibutramine+ microcrystalline cellulose, Reduxin®
Promomed, LLC
Obesity
05/21
05/21
UNLIMITED, NCT05209984: A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

Withdrawn
3
1855
RoW
ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg, EF178 15/75mg, ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg, EF178 15/100mg, SIB Group Sibus (Sibutramine) 15mg, Sibutramine 15mg, Placebo Group, Ef178 Placebo
Eurofarma Laboratorios S.A.
Overweight, Obesity
03/28
03/28
TOLERASIT, NCT05209997: Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

Withdrawn
N/A
1500
RoW
Source document data collection
Eurofarma Laboratorios S.A.
Overweight, Obesity
04/25
12/25
SIBUTAMATE, NCT07588750: Retrospective Evaluation of Sibutramine-Topiramate Therapy for Obesity in Real-World Outpatient Practice

Completed
N/A
278
RoW
Sibutramine + Topiramate
Falquetomed
Obesity & Overweight
08/26
09/26
ACTRN12605000330640: Open Uncontrolled Cohort Study to Assess the Impact of Sibutramine-Assisted Weight Loss in Sleep Apnea in Men

Active, not recruiting
N/A
100
 
NHMRC, NHMRC
Obstructive Sleep Apnea and Obesity
 
 

Download Options